Denosumab Versus Zoledronic Acid in Thalassemia-Induced Osteoporosis

Clinical trial NCT03040765 · TERMINATED

Trial details

NCT number: NCT03040765
Sponsor: Hamad Medical Corporation
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Thalassemia Majors (Beta-Thalassemia Major)Osteoporosis

Start date: 2018-05-14
Primary completion: 2019-04-08
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.